Genesis Healthcare, Inc.
GEN
GEN was delisted on the 25th of March, 2021.
73 hedge funds and large institutions have $33.8M invested in Genesis Healthcare, Inc. in 2017 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 16 reducing their positions, and 12 closing their positions.
31% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 16
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 12
3% less funds holding
Funds holding: 75 → 73 (-2)
10% less capital invested
Capital invested by funds: $37.7M → $33.8M (-$3.9M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VCM
V3 Capital Management
Dallas,
Texas
|
+$2.79M |
| 2 |
CPA
Columbia Pacific Advisors
Seattle,
Washington
|
+$2.2M |
| 3 |
FWC
First Washington Corp
Seattle,
Washington
|
+$1.76M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$552K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$542K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$508K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$350K |
| 3 |
Morgan Stanley
New York
|
-$167K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$144K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$121K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ACI
76
AMP Capital Investors
Sydney,
Australia
| – | -$33K | -19,300 | Closed |
|
|
PCM
77
Prelude Capital Management
New York
| – | -$25K | -14,500 | Closed |
|
78
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$23K | -13,313 | Closed |
|
|
PPA
79
Parametric Portfolio Associates
Seattle,
Washington
| – | -$20K | -11,502 | Closed |
|
|
AIM
80
Acrospire Investment Management
Chicago,
Illinois
| – | -$16K | -9,102 | Closed |
|
81
Creative Planning
Overland Park,
Kansas
| – | -$1K | -300 | Closed |
|
82
Citigroup
New York
| – | +$11 | +9 | +8% |
|
GEN Hedge Fund Activity: Q3 2017 in Review
73 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Genesis Healthcare, Inc. (GEN) for Q3 2017, worth a combined $33.8M — down 10% from $37.7M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of GEN and 11 opened new positions — a net loss of 1 holder — while 16 trimmed existing stakes and 21 added.
The largest buyer was V3 Capital Management, opening a new position worth an estimated $2.79M. The largest seller was Dimensional Fund Advisors, cutting an estimated $508K.
- 73 institutional investors held Genesis Healthcare, Inc. (GEN) as of Q3 2017, down from 75 in Q2 2017.
- Funds reported $33.8M of Genesis Healthcare, Inc. stock for Q3 2017, down 10% quarter-over-quarter.
- 11 funds opened new Genesis Healthcare, Inc. positions in Q3 2017 and 12 closed out, a net change of -1 holder.
- The largest Genesis Healthcare, Inc. buyer in Q3 2017 was V3 Capital Management, an estimated $2.79M added.
- The largest Genesis Healthcare, Inc. seller in Q3 2017 was Dimensional Fund Advisors, an estimated $508K sold.
Based on aggregated 13F filings for Q3 2017.